https://chir-99021inhibitor.co....m/keeping-of-remaini
For the long-term medical effects, patients with frailty had notably even worse outcomes after ESD compared to those without frailty (the 3-year general success rates were 73.2% vs. 93.1per cent; P less then 0.001 with log-rank test). The Cox proportional dangers design showed that frailty was just an independent danger aspect for poor prognosis. CONCLUSIONS ESD for EGC is safe for senior patients with otherwise without frailty. But, elderly customers with frailty have ac
Like
Comment
Share
